4-Star Stocks Poised to Pop: Montpelier Re

Recs

11

Based on the aggregated intelligence of 135,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, specialty reinsurer Montpelier Re Holdings (NYSE: MRH) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Montpelier's business and see what CAPS investors are saying about the stock right now.

Montpelier Re facts

Headquarters (founded)

Pembroke, Bermuda (2001)

Market Cap

$1.19 billion

Industry

Reinsurance

TTM Revenue

$393.5 million

Management

President/CEO Christopher Harris (since 2008)

CFO Michael Paquette (since 2008)

Compound Annual Tangible Book Value Growth (over last three years)

10%

Dividend Yield

2.3%

Competitors

XL Capital (NYSE: XL)

Everest Re (NYSE: RE)

Berkshire Hathaway (NYSE: BRK-A)

CAPS members bullish on MRH also bullish on

Buffalo Wild Wings (Nasdaq: BWLD)

Apple (Nasdaq: AAPL)

CAPS members bearish on MRH also bearish on

Select Comfort (Nasdaq: SCSS)

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, fully 733 of the 752 All-Star members who have rated Montpelier -- some 97% -- believe the stock will outperform the S&P 500 going forward. These bulls include kcacant and CREWatcher, both of whom are ranked in the top 2% of our community.

In March, kcacant tapped the stock as a turnaround play that's actually turning: "P/B is good, insurance losses manageable, insurance pricing is firming up. [Montpelier] did make some bad investments lately (as did I), but other than this, things are looking up."

In a pitch from April, CREWatcher helps firm up that bullishness:

2) A bargain. Priced at under book. I expect price to exceed 1.5 x book after we get through this recession (depression?). Further, I expect book value to improve from here, probably even with confirmation of that later today.
3) Diversifying risk. I like the broadening of coverage types and geography. New London platform will take time to rev up, but should smooth out results over time.
4) Firming reinsurance prices. I hear reinsurance prices are on a firming trend in recent months. Makes sense with capital tight in the current economic environment.
5) Small and under-followed. Lets us small guys capitalize on our advantage of not needing consensus or volume (though volume seems to be here anyway).

What do you think about Montpelier, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 135,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Montpelier, Berkshire, and Apple are all Motley Fool Stock Advisor picks. Montpelier is also a Motley Fool Hidden Gems selection, as is Buffalo Wild Wings. Berkshire is also an Inside Value recommendation. The Fool owns shares of Berkshire and Buffalo Wild Wings. The Fool's disclosure policy always gets a perfect score.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 940387, ~/Articles/ArticleHandler.aspx, 11/8/2009 12:51:10 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Which Companies Can Buy It Like Buffett?

Related Tickers

11/6/2009 4:02 PM
RE $88.05 Up +0.86 +0.99%
Everest Re Group,… CAPS Rating: **
BWLD $42.52 Down -0.02 -0.05%
Buffalo Wild Wings CAPS Rating: ***
BRK-A $102400.00 Up +500.00 +0.49%
Berkshire Hathaway… CAPS Rating: *****
SCSS $5.58 Down -0.21 -3.63%
Select Comfort Cor… CAPS Rating: ***
AAPL $194.34 Up +0.31 +0.16%
Apple, Inc. CAPS Rating: ***
XL $17.22 Up +0.63 +3.80%
XL Capital Ltd. CAPS Rating: **
MRH $16.15 Down -0.08 -0.49%
Montpelier Re Hold… CAPS Rating: *****

Community: Investing Wiki

Term Of The Hour

PDUFA: The Prescription Drug User Fee Act (PDUFA) is a law enacted by Congress that gives powers to the FDA.

Want to learn more or edit this definition?
Click here to read more!